Edwards Lifesciences (EW) Tops Q4 EPS by 4c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Stifel Reiterates Buy Rating on Edwards Lifesciences (EW)
February 12, 2025 1:46 PM ESTStifel analyst Rick Wise reiterated a Buy rating and $90.00 price target on Edwards Lifesciences (NYSE: EW).
The analyst comments "Edwards' 4Q24 performance checked all the critical boxes, including: (1) mid-single-digit TAVR growth (5.3%), despite a 12.1% 4Q23 comp and selling day headwind, suggests that TAVR growth... More
